# Teva Pharmaceutical Industries Limited (TEVA): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/teva for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Drug Manufacturers - Specialty & Generic
- Exchange: NYSE · Trading currency: USD

Teva Pharmaceutical Industries Limited functions as a global pharmaceutical enterprise, involved in the conception, manufacturing, marketing, and provision of a broad spectrum of generic, specialty, and biopharmaceutical products throughout North America, Europe, and various international markets. The company's diverse product range includes sterile items, hormones, potent drugs, and cytotoxic agents, available in numerous forms like tablets, capsules, injectable solutions, inhalable preparations, liquids, transdermal patches, topical ointments, and creams. Additionally, Teva develops, prod...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $39.41 USD |
| Market Cap | $45.92B |
| P/E (TTM) | 17.21 |
| EPS (TTM) | $2.29 |
| 52-Week Range | $19.00 – $42.02 |
| Dividend Yield (TTM) | — |

## Dividend

| Metric | Value |
|---|---|
| Yield (TTM) | — |
| Annual Dividend (TTM) | — /share |
| Annual Dividend (Forward) | — /share |
| Frequency | Quarterly |
| Consecutive Growth Streak | 0 years |
| Growth CAGR 1Y / 3Y / 5Y / 10Y | -75.0% / -35.8% / -19.9% / -1.7% |
| Payout Ratio (EPS, TTM) | — |
| Payout Ratio (FCF, TTM) | — |
| Payout Ratio (EPS, forward dividend) | — |
| Payout Ratio (FCF, forward dividend) | — |

### Recent Payments

| Ex-Date | Amount | Pay Date |
|---|---|---|
| 2017-11-27 | $0.0850 | 2017-12-12 |
| 2017-08-25 | $0.0850 | 2017-09-14 |
| 2017-06-01 | $0.3400 | 2017-06-22 |
| 2017-02-28 | $0.3400 | 2017-03-20 |
| 2016-12-01 | $0.3400 | 2016-12-20 |
| 2016-08-18 | $0.3400 | 2016-09-08 |
| 2016-05-20 | $0.3400 | 2016-06-07 |
| 2016-02-25 | $0.3400 | 2016-03-14 |
| 2015-11-13 | $0.3400 | 2015-12-03 |
| 2015-08-18 | $0.3400 | 2015-09-03 |
| 2015-05-15 | $0.3400 | 2015-06-04 |
| 2015-02-17 | $0.3400 | 2015-03-03 |

Full history: https://www.dividenddata.com/stocks/teva/dividend

## Frequently Asked Questions

### What does Teva Pharmaceutical Industries Limited do?

Teva Pharmaceutical Industries Limited (TEVA) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is TEVA's market cap?

Teva Pharmaceutical Industries Limited (TEVA) has a market capitalization of approximately $45.92 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does TEVA pay a dividend?

No, Teva Pharmaceutical Industries Limited (TEVA) is not currently paying a dividend. Its last ex-dividend date was November 27, 2017 ($0.09 per share), and no payment has been declared since. The full historical payment record is on the Dividend tab.

### How often did TEVA pay dividends?

Teva Pharmaceutical Industries Limited paid dividends quarterly until 2017; nothing has been declared since. Each historical ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is TEVA's payout ratio?

Teva Pharmaceutical Industries Limited's payout ratio is the percentage of earnings (and free cash flow) returned to shareholders as dividends. Current EPS and FCF coverage are shown in the payout cards above, with green / amber / red coloring indicating sustainability.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/teva
- Dividend history & safety: https://www.dividenddata.com/stocks/teva/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/teva/earnings
- Financial statements: https://www.dividenddata.com/stocks/teva/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/teva/valuation
- Peer comparison: https://www.dividenddata.com/stocks/teva/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.